Healthcare

The SUSTAIN 340B Act overhauls the federal drug discount program to tighten oversight and prevent fraud by requiring covered entities to register their contract pharmacies and child sites with the Department of Health and Human Services. It establishes a new independent data clearinghouse to track claims and stop duplicate discounts, while also mandating that health insurers and pharmacy benefit managers treat 340B providers on equal footing without imposing discriminatory reimbursement terms. The bill defines strict criteria for what constitutes a valid patient relationship and authorizes a user fee program starting in fiscal year 2031 to fund additional audits and enforcement activities. These provisions directly affect safety-net healthcare providers, drug manufacturers, and insurance companies by increasing transparency requirements and expanding the government's authority to penalize non-compliance.

The Provider Reimbursement Stability Act of 2026 aims to create more predictable payment amounts for physicians by modifying how the Centers for Medicare & Medicaid Services calculates fee schedules. It raises the financial threshold for certain budget adjustments from $20 million to $57.64 million starting in 2028 and requires these amounts to be adjusted every five years based on inflation data. The bill also mandates that the government update the costs of staff wages and medical supplies used to calculate payments at least once every five years and limits how much the overall payment rate can change from one year to the next to no more than 2.5 percent. These changes directly affect doctors and healthcare providers who receive Medicare payments, ensuring their reimbursement rates remain more stable and better aligned with actual costs.

The More Paid Leave for More Americans Act creates a federal grant program to help states establish or improve paid leave systems that offer up to six weeks of paid time off for reasons like illness, family care, or bonding. To receive funding, states must create a partnership with private entities to manage the program and agree to a national network that standardizes rules and technology across different states. The bill sets specific requirements for benefit amounts, such as providing at least 67 percent of an employee's weekly pay for low-income workers, and allows grants of up to $8 million per state to cover startup costs and ongoing operations. Additionally, the legislation authorizes funding for a national organization to build a shared technology system that helps workers apply for benefits regardless of which states they have worked in.

The Essential Caregivers Act of 2026 requires nursing homes, long-term care hospitals, rehabilitation facilities, and intermediate care facilities to allow two chosen family members or friends to visit residents during times when regular visitation is suspended. These essential caregivers must agree to follow the facility's existing safety and infection control rules, which are no more restrictive than those applied to staff. While facilities can limit access for the first seven days of a suspension or deny entry if a caregiver shows symptoms of a serious infectious disease, they cannot block visits for end-of-life care. Additionally, the bill mandates that complaints about denied access to essential caregivers be investigated and resolved within three days.

The Fair Care Act of 2026 is a comprehensive legislative proposal designed to lower health care costs and improve access by modernizing health savings accounts, expanding insurance coverage options, and increasing transparency in the health care market. The bill directly affects individuals, employers, health insurance issuers, hospitals, and pharmaceutical manufacturers through provisions that allow unused premium tax credits to be deposited into savings accounts, introduce new "copper" insurance plans, and require greater price transparency for hospitals and pharmacy benefit managers. Key mechanisms include the repeal of the employer health insurance mandate, the establishment of a federal reinsurance pool for high-risk individuals, the creation of a conditional approval pathway for drugs treating rare and serious diseases, and the imposition of congressional review procedures for major Food and Drug Administration rules. Additionally, the legislation seeks to promote competition by banning anticompetitive contract terms, regulating co-pay contributions from drug manufacturers, and enforcing stricter price reporting requirements for shoppable medical procedures.

The Take Care of America's Veterans Act is a comprehensive legislative bill designed to improve benefits, healthcare access, and administrative efficiency for veterans and the Department of Veterans Affairs. The bill directly affects veterans, their families, healthcare providers, and VA employees by amending federal laws to expand compensation rates, simplify claims processes, and enhance medical services. Key mechanisms include increasing disability compensation for wartime veterans and survivors, revising disability rating schedules for conditions like sleep apnea and tinnitus, and establishing new grant programs for mental health and traumatic brain injury research. Additionally, the legislation mandates the creation of a Veterans Health Administration Policy Advisory Commission, requires the development of a prosthetic and rehabilitative items formulary, and expands access to care through pilot programs involving critical access hospitals and coordination with Medicare. The act also introduces stricter oversight for claims adjudication, requires timely reporting of veteran deaths, and authorizes funding for various infrastructure and technology improvements within the VA.

This resolution expresses support for designating June 2026 as National Post-Traumatic Stress Awareness Month and June 27, 2026, as National Post-Traumatic Stress Awareness Day. The bill aims to raise public awareness about post-traumatic stress among military members, veterans, and their families while working to reduce the stigma often associated with the condition. By highlighting the importance of education and treatment, the resolution encourages government agencies and the medical community to continue their efforts in addressing the mental health challenges faced by those who have served.

The Take Care of America's Veterans Act is a comprehensive legislative bill designed to improve benefits, healthcare access, and administrative efficiency for veterans and their families. The bill directly affects veterans, their surviving spouses, caregivers, and the Department of Veterans Affairs (VA). Key provisions include expanding disability compensation for combat-related retirees, allowing remarried surviving spouses to retain certain survivor benefits, and increasing compensation rates for specific disability conditions like sleep apnea and tinnitus. The legislation also mandates significant healthcare improvements, such as establishing a pilot program to coordinate care between the VA and Medicare, creating a formulary for prosthetic items, and requiring the VA to provide lactation spaces in all medical centers. Additionally, the bill introduces administrative reforms to speed up claims processing, prohibit denying claims solely for missed medical appointments, and enhance oversight of the VA's disability rating system.

This bill requires the U.S. Food and Drug Administration to review new drug applications from companies based in China to determine if they are affiliated with the Chinese government, Communist Party, or military. If an application comes from such an affiliated entity, the FDA will deny approval for the drug, and U.S. Customs and Border Protection will refuse entry and destroy any imported drugs from these sponsors. The law also allows for a process where affected companies can prove they are no longer affiliated or sell their drug rights to a non-affiliated company within 180 days to avoid having their products blocked. Additionally, the bill authorizes $5 million in funding to carry out these review and enforcement activities.

This resolution expresses support for designating July 15, 2026, as Glioblastoma Awareness Day to raise public awareness about this aggressive and deadly form of brain cancer. The bill honors patients and caregivers while encouraging greater understanding of the urgent medical needs associated with the disease, which currently has a low survival rate and limited treatment options. It also calls for increased collaboration among government, private, and nonprofit organizations to advance research and develop better therapies for those affected.